PFE - Pfizer slips as 2024 guidance with Seagen buyout disappoints
2023-12-13 07:13:01 ET
More on Pfizer
- Johnson & Johnson Vs. Pfizer: Better Pharma Stock?
- Pfizer: This Year's Disaster Should Set The Stage For A Strong 2024
- Pfizer: Slimming Down After COVID Franchise And Obesity Pipeline Setbacks
- Pfizer to close Seagen buyout this week as regulatory reviews complete
- Pfizer's bleeding disorder therapy under review by FDA, EMA
For further details see:
Pfizer slips as 2024 guidance with Seagen buyout disappoints